Quote:

---

A leading academic medical center has administered the test medication, leronlimab, in two of their sickest COVID-19 patients. Neither patient has had any serious adverse reactions to leronlimab since it was administered. We are hopeful leronlimab will provide help to severely ill COVID-19 patients.

---

So, there has been some follow up already.

I would thing both, Dr. Patterson and Dr. Lalezari are "watching like hawks" these patients as they are critical for evaluation and possible administration to other patients.

I would say that many more will follow quickly (drug available + patients available + permission from FDA = multiple treatments) if they continue stable and improve.

Crossing fingers Leronlimab performs in this indication.

Exciting times ahead (one way or another).